Shanghai Pharmaceuticals, one of China’s largest listed pharma groups, has signed a memorandum of understanding (MOU) with the contract logistics firm DHL Supply Chain, to prepare its logistics infrastructure for what the company calls ‘rapid global expansion.’
Under the MOU, the pharma company – which generated revenues of more than $18 billion last year – will partner with DHL Supply Chain to enhance quality control measures, streamline distribution processes, and strengthen compliance with local and international food and pharmaceutical regulations.
“Our partnership with DHL will help Shanghai Pharma to become one of the world’s foremost pharmaceutical manufacturers – supported by a global distribution network that combines world-class quality control with fast, seamless delivery”- said Cho Man, president and executive director at Shanghai Pharma.
No comments:
Post a Comment